Director - Clinical Design Physician – Cardiometabolic Health

Eli Lilly Eli Lilly · Pharma · Indianapolis, IN

Director level physician role focused on clinical study design for cardiometabolic health within a biopharmaceutical company. Responsibilities include translating strategy into study designs, developing protocols, collaborating with cross-functional teams, and disseminating scientific data. The role requires deep understanding of drug development, clinical research, and specific disease states.

What you'd actually do

  1. As the Medical leader on a cross-functional Clinical Design team, translate therapeutic area and asset team strategy into clear objectives and associated clinical development program and trial optionality. Optionality will address business and customer needs (patient, prescriber, payer, and/or regulator); be in alignment with phase of product lifecycle; and clearly articulate associated tradeoffs in value (information gathered, risks created/discharged, cost, and time).
  2. Represent program and trial design optionality to asset teams and Sr. Leaders to inform prioritization of an option that will be translated into a clinical protocol(s). Adjust optionality in accordance with feedback from leadership.
  3. Develop study protocols in collaboration with the Design Team and partners in the Lilly Cardiometabolic Health Business Unit Development Team, Discovery, Program Phase Medicine, and Clinical Pharmacology.
  4. Provide insight into impact of study/protocol design features to execution speed/efficiency.
  5. Contribute to the development of asset strategy (e.g. identification of target patient population) in partnership with the asset team.

Skills

Required

  • Medical leadership
  • Biopharmaceutical industry knowledge
  • Drug development expertise
  • Clinical research experience
  • Clinical study design expertise
  • Cardiometabolic health knowledge
  • Protocol development
  • Cross-functional collaboration
  • Scientific data dissemination
  • Regulatory compliance

Nice to have

  • Experience with decentralized clinical trials
  • Experience with diversity/equity/inclusion in clinical research
  • External expert engagement
  • Professional society collaboration

What the JD emphasized

  • deep understanding of the biopharmaceutical industry
  • drug development
  • clinical research
  • clinical study design
  • Diabetes-associated comorbidities
  • cardiometabolic disease states
  • phase II (proof of concept)
  • phase III (registration)